Trials / Unknown
UnknownNCT04446156
Liver Diseases in PLWH
Epidemiological Investigation of HIV-infected Patients Complicated With Liver Disease in Zhejiang Province
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 3,000 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In Highly Active Antiretroviral Therapy era, fatty liver has become an important cause of liver function damage in people living with HIV (PLWH). There are a large number of PLWH in China who are infected with hepatitis B virus and hepatitis C virus. HIV, hepatitis B virus, hepatitis C virus, drugs, alcohol, etc. affect each other, which makes the cause, diagnosis, and treatment of liver function damage in PLWH complicated in China. The investigators plan to conduct a large-scale questionnaire survey among PLWH in Zhejiang Province to assess liver function, detect liver Injuries early, and analyze HIV, hepatitis B virus, hepatitis C virus, anti-HIV drugs, alcohol and other factors associate with liver injuries in PLWH, to provide basis for the treatment and prevention of liver disease in PLWH in eastern China.
Conditions
Timeline
- Start date
- 2020-05-26
- Primary completion
- 2020-08-31
- Completion
- 2020-12-30
- First posted
- 2020-06-24
- Last updated
- 2020-06-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04446156. Inclusion in this directory is not an endorsement.